共 39 条
[1]
Saif M.W., Reardon J., Management of oxaliplatin-induced peripheral neuropathy, Ther Clin Risk Manag, 1, pp. 249-258, (2005)
[2]
Shah N., Dizon D.S., New-generation platinum agents for solid tumors, Future Oncol, 5, pp. 33-42, (2009)
[3]
Grothey A., Clinical management of oxaliplatin-associated neurotoxicity, Clin Colorectal Cancer, 5, SUPPL. 1, (2005)
[4]
Broomand A., Jerremalm E., Yachnin J., Ehrsson H., Elinder F., Oxaliplatin neurotoxicity-no general ion channel surface-charge effect, J Negat Results Biomed, 8, (2009)
[5]
Cavaletti G., Marmiroli P., Chemotherapy-induced peripheral neurotoxicity, Nature Review Neurology, 6, pp. 657-666, (2011)
[6]
Holmes J., Stanko J., Varchenko M., Ding H., Madden V.J., Bagnell C.R., Wyrick S.D., Chaney S.G., Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model, Toxicol Sci, 46, pp. 342-351, (1998)
[7]
Webster R.G., Brain K.L., Wilson R.H., Grem J.L., Vincent A., Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels, Br J Pharmacol, 146, pp. 1027-1039, (2005)
[8]
Montagnani F., Turrisi G., Marinozzi C., Aliberti C., Fiorentini G., Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unrespectable gastric cancer: a systematic review and meta-analysis, Gastric Cancer, 14, pp. 50-55, (2011)
[9]
Podratz J.L., Knight A.M., Ta L.E., Staff N.P., Gass J.M., Genelin K., Schlattau A., Lathroum L., Windebank A.J., Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons, Neurobiol Dis, 41, pp. 661-668, (2011)
[10]
Shord S.S., Bernard S.A., Lindley C., Blodgett A., Mehta V., Churchel M.A., Poole M., Pescatore S.L., Luo F.R., Chaney S.G., Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity, Anticancer Res, 22, pp. 2301-2309, (2002)